Teladoc Health, Inc. (4LL.F)
EUR 6.2
(1.97%)
EUR 6.2
(1.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 468.6 Million USD | -28.47% |
| 2022 | 655.14 Million USD | 75.19% |
| 2021 | 373.96 Million USD | -48.91% |
| 2020 | 731.97 Million USD | 1595.37% |
| 2019 | -48.94 Million USD | -425.99% |
| 2018 | -9.3 Million USD | -105.66% |
| 2017 | 164.55 Million USD | 3043.18% |
| 2016 | -5.59 Million USD | 80.44% |
| 2015 | -28.58 Million USD | -40.09% |
| 2014 | -20.4 Million USD | -9525.94% |
| 2013 | -212 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 492.32 Million USD | 5.06% |
| 2024 Q2 | 426.45 Million USD | -13.38% |
| 2023 Q4 | 468.6 Million USD | -13.49% |
| 2023 Q2 | 615.09 Million USD | -10.01% |
| 2023 Q3 | 541.65 Million USD | -11.94% |
| 2023 FY | 468.6 Million USD | -28.47% |
| 2023 Q1 | 683.48 Million USD | 4.32% |
| 2022 FY | 655.14 Million USD | 75.19% |
| 2022 Q4 | 655.14 Million USD | -3.07% |
| 2022 Q3 | 675.89 Million USD | -2.99% |
| 2022 Q2 | 696.72 Million USD | -5.4% |
| 2022 Q1 | 736.49 Million USD | 96.94% |
| 2021 Q2 | 453.8 Million USD | -32.57% |
| 2021 FY | 373.96 Million USD | -48.91% |
| 2021 Q3 | 430.27 Million USD | -5.19% |
| 2021 Q4 | 373.96 Million USD | -13.09% |
| 2021 Q1 | 673.01 Million USD | -8.05% |
| 2020 FY | 731.97 Million USD | 1595.37% |
| 2020 Q2 | -326.96 Million USD | -1183.76% |
| 2020 Q3 | -203.48 Million USD | 37.76% |
| 2020 Q1 | -25.46 Million USD | 47.97% |
| 2020 Q4 | 731.97 Million USD | 459.71% |
| 2019 Q2 | 18.5 Million USD | 21.17% |
| 2019 FY | -48.94 Million USD | -425.99% |
| 2019 Q3 | -10.45 Million USD | -156.52% |
| 2019 Q4 | -48.94 Million USD | -368.1% |
| 2019 Q1 | 15.27 Million USD | 264.09% |
| 2018 Q3 | -48.9 Million USD | -116.47% |
| 2018 Q4 | -9.3 Million USD | 80.97% |
| 2018 Q1 | 145.25 Million USD | -11.73% |
| 2018 Q2 | 296.95 Million USD | 104.44% |
| 2018 FY | -9.3 Million USD | -105.66% |
| 2017 Q4 | 164.55 Million USD | -42.91% |
| 2017 Q3 | 288.21 Million USD | 274.26% |
| 2017 FY | 164.55 Million USD | 3043.18% |
| 2017 Q1 | -97.51 Million USD | -1644.12% |
| 2017 Q2 | -165.38 Million USD | -69.61% |
| 2016 Q3 | 437 Thousand USD | 101.79% |
| 2016 Q4 | -5.59 Million USD | -1379.41% |
| 2016 Q2 | -24.39 Million USD | -1.7% |
| 2016 Q1 | -23.98 Million USD | 16.1% |
| 2016 FY | -5.59 Million USD | 80.44% |
| 2015 Q1 | -6.01 Million USD | 70.54% |
| 2015 Q3 | -26.95 Million USD | -256.37% |
| 2015 Q2 | 17.23 Million USD | 386.68% |
| 2015 Q4 | -28.58 Million USD | -6.08% |
| 2015 FY | -28.58 Million USD | -40.09% |
| 2014 Q4 | -20.4 Million USD | 0.0% |
| 2014 FY | -20.4 Million USD | -9525.94% |
| 2013 FY | -212 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| DocCheck AG | -8.51 Million EUR | 5606.16% |
| CompuGroup Medical SE & Co. KGaA | 702.53 Million EUR | 33.298% |
| MeVis Medical Solutions AG | -7.74 Million EUR | 6151.254% |
| Nexus AG | 2.81 Million EUR | -16570.295% |